1. Patterns of brachyury expression in chordomas.
- Author
-
Dridi M, Boutonnat J, Dumollard JM, Peoc'h M, and Karpathiou G
- Subjects
- Adult, Aged, Biomarkers, Tumor metabolism, Chordoma embryology, Chordoma ultrastructure, Clone Cells immunology, Clone Cells metabolism, Decalcification Technique standards, Female, Humans, Immunohistochemistry methods, Male, Middle Aged, Notochord embryology, Notochord pathology, Retrospective Studies, Chordoma diagnosis, Chordoma metabolism, Fetal Proteins metabolism, Neoplasms, Germ Cell and Embryonal pathology, Notochord metabolism, T-Box Domain Proteins metabolism
- Abstract
Introduction: Chordomas are rare malignant midline tumors, presumed to arise from notochordal remnants. This was further suggested by the discovery of the brachyury in chordomas pathogenesis. Its immunohistochemical expression has become the principal adjunct in the diagnosis of chordomas. However, studies about brachyury expression in chordomas are not fully comparable, mainly because they use different primary antibodies. Thus, the aim of this study is to investigate the expression of brachyury expression in a series of chordomas in conjunction to clinicopathological characteristics and to review the relevant literature providing all the details needed in the immunohistochemical study of brachyury., Materials and Methods: This is a retrospective study of 62 chordomas, diagnosed over a 22-year period. No dedifferentiated or poorly differentiated cases were included. A monoclonal primary antibody (clone A-4) was used and brachyury expression was evaluated by the H-score. Clinicopathological parameters studied were age, sex, tumor localization, decalcification status and tissue age. Fetal notochords were used for comparison., Results: Mean H-score of nuclear brachyury expression was 129.8. The tissue age significantly influenced brachyury expression, the older samples expressing less brachyury. Decalcification demonstrated a trend to weaken brachyury expression. Clinical characteristics were not correlated with the patterns of brachyury expression. Notochords were negative. Literature review reveals several polyclonal antibodies used and a positivity of 75%-100% in chordomas with even more variable results in notochords., Conclusion: In chordomas, as in other tumor types, an uniformization of studies about brachyury expression is needed, by considering the clone used, and the decalcification and the age of the sample, given the growing importance of brachyury in diagnosis and therapeutic steps., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF